Behavioral Health AI Data Governance Framework
Build a behavioral health AI data governance framework for inputs, outputs, prompts, models, access, vendors, retention, evaluation, incidents, human review, and accountable change.
On this page: Direct answer
Direct answer
Behavioral health AI data governance: what operators need to know
Build a behavioral health AI data governance framework for inputs, outputs, prompts, models, access, vendors, retention, evaluation, incidents, human review, and accountable change. Inventory prompts, source records, retrieved context, outputs, feedback, logs, embeddings, and evaluation sets. Tie every AI use to an approved purpose, authority, accountable owner, and prohibited-use boundary.
Behavioral-health AI data governance connects each permitted use to the data that enters a system, the data it creates, the people and vendors that can reach it, the evidence used to evaluate it, and the accountable owner who can change or stop the workflow. It covers more than a model or a HIPAA checklist.
Start with a living system-and-data inventory, then govern purpose, authority, minimum-necessary design where applicable, provenance, quality, access, retention, vendor reuse, evaluation, human review, incidents, and retirement. Apply HIPAA, 42 CFR Part 2, contract, state, consent, security, records, and professional requirements to the actual context with qualified counsel and operational owners.
Key takeaways
The short version
- Inventory prompts, source records, retrieved context, outputs, feedback, logs, embeddings, and evaluation sets.
- Tie every AI use to an approved purpose, authority, accountable owner, and prohibited-use boundary.
- Separate production, evaluation, support, analytics, improvement, and model-training uses.
- Require traceability, human review, monitoring, incident response, and a safe stop path.
- Reassess governance when data, vendor, model, prompt, workflow, law, or risk changes.
1. Behavioral health AI data governance inventory
| Data object | Questions to answer | Evidence |
|---|---|---|
| Inputs | Which PHI, Part 2 records, identifiers, free text, audio, images, documents, metadata, or public data enter? | Field map, source, sensitivity, authority, minimization, and validation |
| Context | What instructions, knowledge bases, policies, examples, retrieved records, and tool results shape an output? | Version, provenance, access, freshness, and approval |
| Outputs | What summaries, classifications, messages, decisions, drafts, scores, or actions are created? | Purpose, confidence, evidence, reviewer, correction, and downstream use |
| Telemetry | What prompts, responses, events, errors, latency, quality, safety, and user behavior are logged? | Schema, audience, retention, redaction, access, and monitoring purpose |
| Improvement data | What feedback, corrections, evaluations, test cases, or production examples are reused? | Selection rule, authorization, de-identification claim, separation, retention, and deletion |
| Derived stores | What embeddings, indexes, caches, transcripts, backups, exports, or vendor support copies exist? | Location, encryption, tenant boundary, lifecycle, recovery, and destruction evidence |
2. Establish purposes, decision rights, and prohibitions
- Approved use case, population, channel, program, jurisdiction, decision, user, and measurable intended benefit
- Executive, operational, privacy, security, clinical, legal, data, model, vendor, and incident-accountability roles
- Data uses allowed for production, support, analytics, evaluation, product improvement, and training
- Prohibited autonomous decisions and required human review for crisis, clinical, coverage, placement, consent, or other high-consequence work
- Authority to approve, change, suspend, roll back, disclose, export, retain, delete, and retire
- Appeal, correction, complaint, accessibility, language-access, and alternative-channel paths for affected people
3. Control the AI data lifecycle
- 01
Collect and validate
Limit inputs to the approved purpose, distinguish required from optional data, validate identity and context, and prevent unsupported data from silently driving a result.
- 02
Process and retrieve
Enforce role, tenant, purpose, and record-level permissions across prompts, tools, knowledge retrieval, integrations, and administrator access.
- 03
Generate and review
Show evidence, uncertainty, model and prompt version, reviewer requirements, prohibited actions, and a clear correction or deferral path.
- 04
Store and monitor
Apply encryption, audit events, data-loss controls, retention, deletion, backups, access review, and monitoring to outputs and hidden derived stores.
- 05
Reuse or disclose
Authorize production data reuse, support access, vendor improvement, model training, disclosure, and export separately; do not infer permission from technical availability.
- 06
Retire
Disable access and integrations, preserve required evidence, return or destroy data, test deletion obligations, remove stale copies, and document residual risk.
4. Govern evaluation, drift, and change
| Control | Minimum record | Release question |
|---|---|---|
| Test design | Use cases, harms, cohorts, edge cases, languages, adversarial tests, thresholds, and owners | Does the evaluation represent the deployed workflow and affected users? |
| Data quality | Provenance, labeling, missingness, disagreement, leakage, recency, and exclusions | Can the evidence support the claim being made? |
| Human review | Reviewer qualifications, rubric, disagreement, overrides, correction, and workload | Is review meaningful, timely, and authorized? |
| Production monitoring | Quality, safety, access, privacy, security, latency, exceptions, complaints, and outcomes | Will a material failure be detected before unacceptable harm? |
| Change control | Data, prompt, model, vendor, tool, policy, integration, threshold, and rollout differences | Does the change require new testing, notice, approval, or rollback readiness? |
5. Maintain an auditable governance record
- Current system, data-flow, subprocessors, locations, integrations, and authoritative owner inventory
- Risk analysis, privacy and Part 2 analysis, contract decisions, control evidence, and accepted residual risks
- Approved use, prohibited use, user notice, human-review design, procedures, training, and access reviews
- Evaluation plans, datasets, results, limitations, release approvals, model cards or equivalent records, and monitored thresholds
- Prompt, knowledge, model, integration, policy, and configuration versions connected to production events
- Incidents, near misses, complaints, corrections, overrides, disclosures, remediation, and lessons incorporated
- Retention, deletion, export, backup, recovery, suspension, rollback, vendor exit, and retirement tests
Common questions
Answers before you build.
What is behavioral health AI data governance?+
It is the accountable system for approving, mapping, controlling, evaluating, monitoring, changing, and retiring AI data uses across inputs, outputs, prompts, retrieval, logs, feedback, vendors, people, and downstream actions.
Does de-identifying data remove all AI governance obligations?+
No. The de-identification method and residual risk need support, and contracts, security, consent, confidentiality, state law, ethics, re-identification risk, purpose, quality, and downstream-use concerns may remain.
Can a vendor use behavioral-health data to train its models?+
Do not assume so. Analyze applicable law, purpose, authorization or permission, contracts, representations, minimum-necessary principles where applicable, Part 2 scope, security, retention, deletion, provenance, and organizational policy for that separate use.
How often should AI data governance be reviewed?+
Use recurring review plus event-triggered review when the data, population, purpose, law, model, prompt, retrieval source, vendor, subprocessor, integration, human-review step, incident, complaint, or observed performance changes.
Practical closeout
Use this operator checklist.
- Inventory prompts, source records, retrieved context, outputs, feedback, logs, embeddings, and evaluation sets.
- Tie every AI use to an approved purpose, authority, accountable owner, and prohibited-use boundary.
- Separate production, evaluation, support, analytics, improvement, and model-training uses.
- Require traceability, human review, monitoring, incident response, and a safe stop path.
- Reassess governance when data, vendor, model, prompt, workflow, law, or risk changes.
Continue through the cluster
Verified customer case studies are added only with customer permission and supporting evidence; none is implied by these operational examples.
Sources & methodology
Trace the operational claims.
Marsa Health Editorial reviewed the primary and research sources below on July 22, 2026. We translate them into workflow controls, distinguish proposals from final rules, and flag where plan, program, state, contract, or clinical requirements vary.
- 01AI Risk Management Framework Core National Institute of Standards and TechnologyVoluntary framework for governing, mapping, measuring, and managing AI risks, including defined roles for human-AI oversight.Accessed or rechecked July 22, 2026
- 02Artificial Intelligence Risk Management Framework: Generative Artificial Intelligence Profile National Institute of Standards and TechnologyNIST companion profile for generative AI risks, governance, pre-deployment testing, content provenance, incident disclosure, and human review.Accessed or rechecked July 22, 2026
- 03Guidance on Risk Analysis U.S. Department of Health and Human ServicesOfficial guidance that risk analysis must cover all ePHI an organization creates, receives, maintains, or transmits.Accessed or rechecked July 22, 2026
- 04Summary of the HIPAA Security Rule U.S. Department of Health and Human ServicesCurrent Security Rule overview covering administrative, physical, and technical safeguards, access controls, risk analysis, and review of ePHI activity.Accessed or rechecked July 22, 2026
- 05Guidance on HIPAA and Cloud Computing U.S. Department of Health and Human ServicesOCR guidance on cloud business associates, subcontractors, BAAs, risk analysis, shared security responsibilities, SLAs, data return, and breach duties.Accessed or rechecked July 22, 2026
- 06Understanding Confidentiality of Substance Use Disorder Patient Records or Part 2 U.S. Department of Health and Human ServicesCurrent OCR overview of Part 2 scope, the 2024 final rule, the February 16, 2026 compliance date, enforcement, breach reporting, and model notices.Accessed or rechecked July 22, 2026
- 07Minimum Necessary Requirement U.S. Department of Health and Human ServicesHIPAA guidance on limiting uses, disclosures, and requests for protected health information when the standard applies.Accessed or rechecked July 22, 2026
- 08Business Associate Contracts U.S. Department of Health and Human ServicesOCR explanation and sample provisions covering permitted uses, safeguards, incidents, individual rights, subcontractors, termination, and return or destruction.Accessed or rechecked July 22, 2026
Organizational author. Editorial review covers source accuracy, search intent, workflow boundaries, and human-oversight requirements. This material is educational and does not provide clinical, legal, coding, or coverage advice.
No named clinical or legal expert reviewer is attributed to this version. Marsa Health does not invent reviewer credentials.
Read our editorial methodRevision history
What changed and when
July 22, 2026
Initial publication, source review, and operational editing.